Continue to site >
Trending ETFs
You have successfully subscribed to Advisor Access. Thank you!
Help us personalize your experience.
Which type of investor describes you best?
Help us personalize your experience.
What is your AUM?
Knowing your investable assets will help us build and prioritize features that will suit your investment needs.

Congratulations on personalizing your experience.

Email is verified. Thank you!

Name

As of 12/24/2024

Price

Aum/Mkt Cap

YIELD

Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.

Exp Ratio

Expense ratio is the fund’s total annual operating expenses, including management fees, distribution fees, and other expenses, expressed as a percentage of average net assets.

Watchlist

BlackRock ETF Trust - iShares Health Innovation Active ETF

BMED | ETF

$25.32

$1.29 B

0.00%

-

Vitals

YTD Return

3.3%

1 yr return

3.3%

3 Yr Avg Return

-4.4%

5 Yr Avg Return

N/A

Net Assets

$1.29 B

Holdings in Top 10

N/A

52 WEEK LOW AND HIGH

$25.1
$24.03
$26.56

Expenses

OPERATING FEES

Expense Ratio N/A

SALES FEES

Front Load N/A

Deferred Load N/A

TRADING FEES

Turnover N/A

Redemption Fee N/A

Min Investment

Standard (Taxable)

N/A

IRA

N/A

Fund Classification

Fund Type

Exchange Traded Fund

Name

As of 12/24/2024

Price

Aum/Mkt Cap

YIELD

Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.

Exp Ratio

Expense ratio is the fund’s total annual operating expenses, including management fees, distribution fees, and other expenses, expressed as a percentage of average net assets.

Watchlist

BlackRock ETF Trust - iShares Health Innovation Active ETF

BMED | ETF

$25.32

$1.29 B

0.00%

-

BMED - Profile

Distributions

  • YTD Total Return 3.3%
  • 3 Yr Annualized Total Return -4.4%
  • 5 Yr Annualized Total Return N/A
  • Capital Gain Distribution Frequency N/A
  • Net Income Ratio N/A
DIVIDENDS
  • Dividend Yield 0.0%
  • Dividend Distribution Frequency SemiAnnual

Fund Details

  • Legal Name
    BlackRock ETF Trust - iShares Health Innovation Active ETF
  • Fund Family Name
    BlackRock-advised Funds
  • Inception Date
    Oct 01, 2020
  • Shares Outstanding
    N/A
  • Share Class
    N/A
  • Currency
    USD
  • Domiciled Country
    US
  • Manager
    Xiang Liu

Fund Description

BMED - Performance

Return Ranking - Trailing

Period BMED Return Category Return Low Category Return High Rank in Category (%)
YTD 3.3% -25.6% 23.4% 97.21%
1 Yr 3.3% -30.0% 21.8% 96.41%
3 Yr -4.4%* -18.7% 19.7% N/A
5 Yr N/A* -14.7% 15.3% N/A
10 Yr N/A* -6.2% 15.7% N/A

* Annualized

Return Ranking - Calendar

Period BMED Return Category Return Low Category Return High Rank in Category (%)
2023 5.7% -53.9% 11.7% 10.30%
2022 -19.7% -22.3% 18.5% N/A
2021 -4.0% -4.7% 41.4% N/A
2020 N/A -10.2% 13.1% N/A
2019 N/A -5.7% 26.9% N/A

Total Return Ranking - Trailing

Period BMED Return Category Return Low Category Return High Rank in Category (%)
YTD 3.3% -41.2% 23.4% 97.21%
1 Yr 3.3% -30.0% 28.3% 96.61%
3 Yr -4.4%* -18.7% 19.7% N/A
5 Yr N/A* -14.7% 15.3% N/A
10 Yr N/A* -6.2% 15.7% N/A

* Annualized

Total Return Ranking - Calendar

Period BMED Return Category Return Low Category Return High Rank in Category (%)
2023 5.7% -53.9% 11.7% 10.30%
2022 -19.7% -22.3% 18.5% N/A
2021 -4.0% -4.7% 41.4% N/A
2020 N/A -10.2% 13.1% N/A
2019 N/A -5.7% 26.9% N/A

BMED - Holdings

Concentration Analysis

BMED Category Low Category High BMED % Rank
Net Assets 1.29 B 732 K 46.2 B 87.43%
Number of Holdings N/A 21 473 17.28%
Net Assets in Top 10 N/A 2.18 K 21.6 B 93.19%
Weighting of Top 10 N/A 12.3% 80.8% 94.24%

Top 10 Holdings

  1. BlackRock Cash Funds Treasury SL Agency 4.97%
  2. Seattle Genetics Inc 3.76%
  3. Genmab A/S 3.54%
  4. Genmab A/S 3.54%
  5. Genmab A/S 3.54%
  6. Genmab A/S 3.54%
  7. Genmab A/S 3.54%
  8. Genmab A/S 3.54%
  9. Genmab A/S 3.54%
  10. Genmab A/S 3.54%

Asset Allocation

Weighting Return Low Return High BMED % Rank
Stocks 		94.94% 85.37% 106.13% 90.05%
Preferred Stocks 		0.00% 0.00% 7.86% 97.38%
Other 		0.00% -22.99% 3.38% 91.62%
Convertible Bonds 		0.00% 0.00% 0.37% 97.38%
Cash 		0.00% -0.10% 9.01% 8.38%
Bonds 		0.00% 0.00% 12.39% 97.38%

BMED - Expenses

Operational Fees

BMED Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Expense Ratio N/A 0.08% 3.13% 47.94%
Management Fee N/A 0.00% 1.25% 89.07%
12b-1 Fee N/A 0.00% 1.00% N/A
Administrative Fee N/A 0.03% 0.25% N/A

Sales Fees

BMED Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Front Load N/A 0.00% 5.75% N/A
Deferred Load N/A 1.00% 5.00% N/A

Trading Fees

BMED Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Max Redemption Fee N/A 1.00% 1.00% N/A

Related Fees

Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.

BMED Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Turnover N/A 0.00% 238.00% N/A

BMED - Distributions

Dividend Yield Analysis

BMED Category Low Category High BMED % Rank
Dividend Yield 0.00% 0.00% 2.44% 95.92%

Dividend Distribution Analysis

BMED Category Low Category High Category Mod
Dividend Distribution Frequency SemiAnnual Annually Quarterly Annually

Net Income Ratio Analysis

BMED Category Low Category High BMED % Rank
Net Income Ratio N/A -2.54% 1.92% 79.29%

Capital Gain Distribution Analysis

BMED Category Low Category High Capital Mode
Capital Gain Distribution Frequency Annually Annually Annually

Distributions History

View More +

BMED - Fund Manager Analysis

Managers

Xiang Liu

Start Date

Tenure

Tenure Rank

Sep 29, 2020

1.67

1.7%

Director of BlackRock since 2016. Prior to joining BlackRock in 2008, Mr. Liu was a Partner and Biotech Analyst at Mehta Partners. Mr. Liu began his investment career in 2000 and has a BS from the University of Science & Technology (China), an MBA from the University of Chicago and a PhD degree in Chemistry from Yale University.

Erin Xie

Start Date

Tenure

Tenure Rank

Sep 29, 2020

1.67

1.7%

Ms. Xie is the managing director and Portfolio Manager of BlackRock Advisor since 2006. Before becoming part of BlackRock Advisors in 2005, she was with State Street Research & Management since 2001. Ms. Xie began her investment career as a pharmaceutical analyst for Sanford Bernstein in 1999.

Jeff Lee

Start Date

Tenure

Tenure Rank

Sep 29, 2020

1.67

1.7%

Director of BlackRock since 2011. Mr. Lee began his investment career in 2006 and has a BA from Princeton University

Tenure Analysis

Category Low Category High Category Average Category Mode
0.02 24.72 7.26 2.12

Advertisement

×

Wait! Do you know all the important aspects of mutual funds?

×

Free Advisor Access newsletter emailed to you.

Receive free and exclusive email updates for financial advisors about best performers, news, CE accredited webcasts and more.

Sign up for Advisor Access

Receive email updates about best performers, news, CE accredited webcasts and more.

Disclaimer: By registering, you agree to share your data with MutualFunds.com and opt-in to receiving occasional communications about projects and events. The contents of this form are subject to the MutualFunds.com Privacy Policy. You can unsubscribe at any time.